References
- Global initiative of chronic obstructive lung disease: global strategy for the diagnosis and management and prevention of chronic obstructive lung disease. 2017. Available from: https://goldcopd.org/gold-2017-global-strategy-diagnosis-management-prevention-copd/
- Quaderi SA, Hurst JR. The unmet global burden of COPD. Glob Health Epidemiol Genom. 2018;3:e4.doi:10.1017/gheg.2018.1.
- Perng DW, Chen PK. The relationship between airway inflammation and exacerbation in chronic obstructive pulmonary disease. Tuberc Respir Dis. 2017;80(4):325–335. doi:10.4046/trd.2017.0085.
- Comes A, Ianoşi ES, Jimborean G. Inflammatory biomarkers in chronic obstructive pulmonary disease. J. Interdiscip Med. 2016;1(1):12–17. doi:10.1515/jim-2016-0004.
- Zhu M, Wang T, Wang C, et al. The association between vitamin D and COPD risk, severity, and exacerbation: an updated systematic review and meta-analysis. Int J Chron Obstruct Pulmon Dis. 2016;11:2597–2607. doi:10.2147/COPD.S101382.
- Laird E, McNulty H, Ward M, et al. Vitamin D deficiency is associated with inflammation in older Irish adults. J Clin Endocrinol Metab. 2014;99(5):1807–1815. doi:10.1210/jc.2013-3507.
- Gonçalves de Carvalho CMR, Ribeiro S. Aging, low-grade systemic inflammation and vitamin D: a mini-review. Eur J Clin Nutr. 2017;71(4):434–440. doi:10.1038/ejcn.2016.177.
- Herr C, Greulich T, Koczulla RA, et al. The role of vitamin D in pulmonary disease: COPD, asthma, infection, and cancer. Respir Res. 2011;12(1):31–31. doi:10.1186/1465-9921-12-31.
- Pfeffer PE, Lu H, Mann EH, et al. Effects of vitamin D on inflammatory and oxidative stress responses of human bronchial epithelial cells exposed to particulate matter. PLoS One. 2018;13(8):e0200040. doi:10.1371/journal.pone.0200040.
- McNally JD, Iliriani K, Pojsupap S, et al. Rapid normalization of vitamin D levels: a meta-analysis. Pediatrics. 2015;135(1):e152. doi:10.1542/peds.2014-1703.
- Cannell JJ, Grant WB, Holick MF. Vitamin D and inflammation. Dermatoendocrinology. 2014;6(1):e983401. doi:10.4161/19381980.2014.983401.
- Barnes PJ. Inflammatory mechanisms in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2016;138(1):16–27. doi:10.1016/j.jaci.2016.05.011.
- Zendedel A, Gholami M, Anbari K, et al. Effects of vitamin D intake on FEV1 and COPD exacerbation: a randomized clinical trial study. Glob J Health Sci. 2015;7(4):243–248. doi:10.5539/gjhs.v7n4p243.
- Pourrashid MH, Dastan F, Salamzadeh J, et al. Role of vitamin D replacement on health related quality of life in hospitalized patients with “acute exacerbation of chronic obstructive pulmonary disease. Iran J Pharm Res. 2018;17(2):801–810.
- Rezk N, Aly NYA, Hewidy A. Effect of vitamin D replacement in chronic obstructive pulmonary disease patients with vitamin D deficiency. Egypt J Chest Dis Tuberc. 2015;64(2):353–357. doi:10.1016/j.ejcdt.2015.01.002.
- Jolliffe DA, Greenberg L, Hooper RL, et al. Vitamin D to prevent exacerbations of COPD: systematic review and meta-analysis of individual participant data from randomised controlled trials. Thorax. 2019;74(4):337–345. doi:10.1136/thoraxjnl-2018-212092.
- Chang C, Guo Z, Shen N, et al. Dynamics of inflammation resolution and symptom recovery during AECOPD treatment. Sci Rep. 2015;4(1):5516. doi:10.1038/srep05516.
- Su B, Liu T, Fan H, et al. Inflammatory markers and the risk of chronic obstructive pulmonary disease: a systematic review and meta-analysis. PLoS One. 2016;11(4):e0150586. doi:10.1371/journal.pone.0150586.
- Lehouck A, Mathieu C, Carremans C, et al. High doses of vitamin D to reduce exacerbations in chronic obstructive pulmonary disease: a randomized trial. Ann Intern Med. 2012;156(2):105–114. doi:10.7326/0003-4819-156-2-201201170-00004.
- Huang AX, Lu LW, Liu WJ, et al. Plasma inflammatory cytokine IL-4, IL-8, IL-10, and TNF-alpha levels correlate with pulmonary function in patients with asthma-chronic obstructive pulmonary disease (COPD) overlap syndrome. Med Sci Monit. 2016;22:2800–2808. doi:10.12659/MSM.896458.
- Singh S, Verma SK, Kumar S, et al. Association between serum cytokine levels and severity of chronic obstructive pulmonary disease in Northern India. Int J Innovation Sci Res. 2015;18(2):357–361.
- Gupta R, Kaur R, Singh V, et al. Serial estimation of serum CRP levels in patients of COPD with acute exacerbation. Gobal J Med Public Health. 2012;1(6):1–10.
- Han J, Cheng C, Zhu Z, et al. Vitamin D reduces the serum levels of inflammatory cytokines in rat models of periodontitis and chronic obstructive pulmonary disease. J Oral Sci. 2019;61(1):53–60. doi:10.2334/josnusd.17-0357.
- Dimeloe S, Rice LV, Chen H, et al. Vitamin D (1,25(OH)2D3) induces α-1-antitrypsin synthesis by CD4+ T cells, which is required for 1,25(OH)2D3-driven IL-10. J Steroid Biochem Mol Biol. 2019;189:1–9. doi:10.1016/j.jsbmb.2019.01.014.
- Zhou W, Wang Q. Vitamin D suppresses lipopolysaccharide-induced inflammatory response in vascular smooth muscle cells via inhibition of the p38 MAPK signaling pathway. Pharmazie. 2019;74(3):168–174. doi:10.1691/ph.2019.8818.
- Ke CY, Yang FL, Wu WT, et al. Vitamin D3 reduces tissue damage and oxidative stress caused by exhaustive exercise. Int J Med Sci. 2016;13(2):147–153. doi:10.7150/ijms.13746.